GF Fund Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$359K Sell
575
-29
-5% -$17K ﹤0.01% 229
2026
Q2
$320K Sell
604
-28
-4% -$12.9K ﹤0.01% 235
2026
Q1
$303K Buy
632
+80
+14% +$41K 0.01% 252
2025
Q4
$310K Sell
552
-52
-9% -$29.5K 0.01% 252
2025
Q3
$311K Sell
604
-192
-24% -$83.8K 0.01% 252
2025
Q2
$250K Hold
796
– – 0.01% 304
2025
Q1
$243K Buy
796
+143
+22% +$48.1K 0.01% 306
2024
Q4
$217K Buy
+653
New +$221K ﹤0.01% 283

Other funds holding MEDP

GF Fund Management's MEDP Position: Q3 2026 in Review

GF Fund Management reduced its Medpace (MEDP) stake by 4.8% in Q3 2026, selling an estimated $17K and leaving 575 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #229.

GF Fund Management first reported a position in MEDP in Q4 2024 and has held it in 8 quarters since. 396 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • GF Fund Management held 575 shares of Medpace worth $359K as of Q3 2026.
  • GF Fund Management sold 29 Medpace shares in Q3 2026, an estimated $17K.
  • Medpace made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #229 holding.
  • GF Fund Management first reported a position in Medpace in Q4 2024 and has held it in 8 quarters since.
  • 396 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.